This threshold effect could also explain the paradox of the strategy to target the eIF6–60S interaction interface in cancers to inhibit growth whereas targeting the same interface in SDS patients can be used to rescue the slow growth phenotype and cellular fitness. The gene discussed is EIF6; the disease is cancer.